For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The risk: cancer.

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

IOWA’S NEWS LEADER. ALL RIGHT. BO. THANK YOU. NEW AT SIX. NEARLY 500 U.S. CELLULAR EMPLOYEES IN IOWA WILL LOSE THEIR JOBS IN JUNE. THAT’S ACCORDING TO IOWA WORKFORCE DEVELOPMENT HERE IN THE CENTRAL ...

First human gets experimental gene shot to rewind ageing cells in the eye Life Biosciences has dosed its first patient with ER-100, a treatment that uses partial cellular reprogramming to target ...

The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

A team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences (IN), a joint center of the Spanish National Research Council (CSIC) and the Miguel Hernández University of Elche ...

HAYA Therapeutics Announces First Cohort Dosed in Phase 1 Clinical Trial of HTX-001, an Investigational Precision Cellular Reprogramming Therapy for Cardiac Fibrosis HTX-001 is a first-in-class ...

HTX-001 is a first-in-class antisense oligonucleotide designed to downregulate WISPER lncRNA, a driver of fibrosis in the heart Phase 1a/b trial to evaluate the safety and tolerability of HTX-001 in ...

OF APPLE’S REVENUE. REVENUE. U.S. CELLULAR PLANS TO LAY OFF THOUSANDS OF POSITIONS ACROSS THE COUNTRY. SOME EMPLOYEES IN IOWA COULD BE IMPACTED. IN A NOTICE FROM THE PHONE CARRIER. THEY’RE ELIMINATING ...

Gear-obsessed editors choose every product we review. We may earn commission if you buy from a link. Why Trust Us? Here’s what you’ll learn when you read this story: A scientist wants to reprogram ...